These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12515737)

  • 1. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Sousa JE; Costa MA; Abizaid A; Sousa AG; Feres F; Mattos LA; Centemero M; Maldonado G; Abizaid AS; Pinto I; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2003 Jan; 107(1):24-7. PubMed ID: 12515737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries.
    Sousa JE; Costa MA; Sousa AG; Abizaid AC; Seixas AC; Abizaid AS; Feres F; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2003 Jan; 107(3):381-3. PubMed ID: 12551858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience.
    Degertekin M; Regar E; Tanabe K; Smits PC; van der Giessen WJ; Carlier SG; de Feyter P; Vos J; Foley DP; Ligthart JM; Popma JJ; Serruys PW
    J Am Coll Cardiol; 2003 Jan; 41(2):184-9. PubMed ID: 12535805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
    Sousa JE; Costa MA; Abizaid AC; Rensing BJ; Abizaid AS; Tanajura LF; Kozuma K; Van Langenhove G; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Oct; 104(17):2007-11. PubMed ID: 11673337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ; Vos J; Smits PC; Foley DP; van den Brand MJ; van der Giessen WJ; de Feijter PJ; Serruys PW
    Eur Heart J; 2001 Nov; 22(22):2125-30. PubMed ID: 11686669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study.
    Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Feres F; Staico R; Centemero M; Tanajura LF; Abizaid AC; Rodrigues A; Paes A; Mintz GS; Sousa JE
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):535-40. PubMed ID: 16283682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation.
    Colombo A; Orlic D; Stankovic G; Corvaja N; Spanos V; Montorfano M; Liistro F; Carlino M; Airoldi F; Chieffo A; Di Mario C
    Circulation; 2003 May; 107(17):2178-80. PubMed ID: 12719283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents.
    Sousa JE; Costa MA; Abizaid A; Feres F; Seixas AC; Tanajura LF; Mattos LA; Falotico R; Jaeger J; Popma JJ; Serruys PW; Sousa AG
    Circulation; 2005 May; 111(18):2326-9. PubMed ID: 15851603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
    Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC;
    Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-dimensional intravascular ultrasound comparison between the new zotarolimus-eluting stent (ZoMaxx) and the non-drug-eluting TriMaxx stent.
    Lasave LI; Costa Jde R; Abizaid AA; Feres F; Tanajura LF; Staico R; Abizaid AA; Beraldo P; Sousa AM; Sousa JE
    J Invasive Cardiol; 2007 Jul; 19(7):303-8. PubMed ID: 17620675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.
    Hong MK; Mintz GS; Lee CW; Park DW; Choi BR; Park KH; Kim YH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Eur Heart J; 2006 Jun; 27(11):1305-10. PubMed ID: 16682378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.
    Carrié D; Delarche N; Piot C; Berland J; Menneveau N; Bonello L; Py A; Teiger E; Leborgne L; Bayet G; Wittenberg O; Schiele F
    EuroIntervention; 2014 Oct; 10(6):700-8. PubMed ID: 24334825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
    Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
    Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
    Sousa JE; Costa MA; Abizaid A; Abizaid AS; Feres F; Pinto IM; Seixas AC; Staico R; Mattos LA; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Jan; 103(2):192-5. PubMed ID: 11208675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.